
1w3 min read
Medical Article
Introduction Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy characterized by motor and sensory dysfunction, often managed with IVIg, corticosteroids, or plasma exchange. Despite available treatments, relapse, incomplete response, and long-term dependency remain common challenges. Complement activity has be

Phase 2 Evaluation of Riliprubart in Chronic Inflammatory Demyelinating Polyneuropathy
1 Reached
Similar Content

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes

Spinal Anesthesia in Elderly Patient
4200 Reached10 Comments7 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Neurotrophic Deep Corneal Ulcer in Old Male
1139 Reached5 Comments4 Likes